Application 040263

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 50MG BASE/2ML (EQ 25MG BASE/ML)NoYes
002METHOTREXATE SODIUMMETHOTREXATE SODIUMINJECTABLE;INJECTIONEQ 250MG BASE/10ML (EQ 25MG BASE/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63323-123MethotrexateMETHOTREXATE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-123MethotrexateMETHOTREXATE SODIUMFresenius Kabi USA, LLCANDACurrent
63323-123MethotrexateMETHOTREXATE SODIUMFresenius Kabi USA, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
17759ORIG2004-06-09
22109ORIG2003-07-31
29905ORIG1999-02-26